Provided by Tiger Trade Technology Pte. Ltd.

BridgeBio Pharma, Inc.

67.25
+0.34000.51%
Post-market: 67.250.00000.00%16:15 EDT
Volume:2.65M
Turnover:178.11M
Market Cap:13.17B
PE:-18.84
High:68.68
Open:67.10
Low:66.23
Close:66.91
52wk High:93.42
52wk Low:51.85
Shares:195.81M
Float Shares:167.00M
Volume Ratio:0.88
T/O Rate:1.58%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.5686
EPS(LYR):-3.7850
ROE:-1789.67%
ROA:-26.00%
PB:-5.24
PE(LYR):-17.77

Loading ...

BridgeBio Pharma CEO Neil Kumar Disposes of USD 3.07 Million in Common Shares

Reuters
·
Aug 21

BridgeBio Pharma's Transition to Rare Disease 'Commercial Powerhouse' On Track, RBC Says

MT Newswires Live
·
Aug 14

Analysts Are Bullish on Top Healthcare Stocks: BridgeBio Pharma (BBIO), Pyxis Oncology (PYXS)

TIPRANKS
·
Aug 14

BridgeBio Pharma, - Announces Pricing of 5,000,000 Share Secondary Offering by KKR Genetic Disorder L.p.

THOMSON REUTERS
·
Aug 14

BridgeBio Launches Secondary Offering of 5,000,000 Shares by KKR Genetic Disorder LP

Reuters
·
Aug 14

BridgeBio Pharma Announces Launch of Secondary Offering of Common Stock on Behalf of an Existing Shareholder

THOMSON REUTERS
·
Aug 14

Omeros Q2 Yartemlea Net Revenue Jumps 190%

Reuters
·
Aug 13

BridgeBio Pharma is Maintained at Buy by Truist Securities

Dow Jones
·
Aug 13

Liquidia Q2 Revenue Jumps on Yutrepia Sales

Reuters
·
Aug 12

U.S. Research Roundup-Cardinal Health, Lumentum Holdings, Public Storage

Reuters
·
Aug 12

BridgeBio Oncology Therapeutics Beri Opsi Saham 65.350 Lembar Kepada Dua Karyawan Baru Dengan Harga Pelaksanaan USD 9,28

Reuters
·
Aug 12

Bridgebio Pharma Reports Inducement Grants Under NASDAQ Listing Rule

Reuters
·
Aug 12

BridgeBio Memberi 66.705 Unit Saham Terbatas Kepada 56 Karyawan Baru

Reuters
·
Aug 12

BridgeBio Pharma Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

THOMSON REUTERS
·
Aug 12

BridgeBio Pharma Price Target Raised to $104.00/Share from $101.00 by B of a Securities

Dow Jones
·
Aug 12

BridgeBio Posted Q2 Revenue Beat, but Faces Higher Near-Term Launch Opex, Morgan Stanley Says

MT Newswires Live
·
Aug 11

Analysts Offer Insights on Healthcare Companies: Cardinal Health (CAH), Axsome Therapeutics (AXSM) and BridgeBio Pharma (BBIO)

TIPRANKS
·
Aug 11

BridgeBio Pharma, Inc. : Truist Securities Raises Target Price to $107 from $102

THOMSON REUTERS
·
Aug 11

BridgeBio Pharma : Bofa Global Research Raises Price Objective to $104.00 from $101.00

THOMSON REUTERS
·
Aug 11

BridgeBio price target lowered to $97 from $98 at Morgan Stanley

TIPRANKS
·
Aug 11